Prestige Consumer Healthcare (PBH) Revenue (2010 - 2025)

Prestige Consumer Healthcare's Revenue history runs 16 years deep, the most recent figure standing at $283.4 million for Q4 2025.

• On a quarterly basis, Revenue fell 2.37% year-over-year to $283.4 million in Q4 2025; TTM through Dec 2025 was $1.1 billion, a 1.31% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 1.1% from the prior year.
• Revenue improved to $283.4 million in Q4 2025 per PBH's latest filing, from $274.1 million in the prior quarter.
• Across five years, Revenue topped out at $296.5 million in Q1 2025 and bottomed at $237.8 million in Q1 2021.
• The 5-year median for Revenue is $277.0 million (2022), against an average of $276.1 million.
• Across the five-year window, Revenue climbed 17.34% in 2021 and decreased 6.59% in 2025, its largest moves.
• Year by year, Revenue stood at $274.5 million in 2021, then grew by 0.38% to $275.5 million in 2022, then climbed by 2.62% to $282.7 million in 2023, then grew by 2.68% to $290.3 million in 2024, then retreated by 2.37% to $283.4 million in 2025.
• Per Business Quant, the three latest PBH Revenue figures stand at $283.4 million (Q4 2025), $274.1 million (Q3 2025), and $249.5 million (Q2 2025).